Listen, I was told about AVITA approximately a year ago when it was still on the OTC at 1.93, i bought 1000 shares then, at that price and then at$3,35 and then 5.00, and then 7.75 which I think was around the time it became RCEL on the Nasdaq. Also bought today at 10.39
Point is that Polynovo’s product works well withRecell and it is patented. I see no reason that their product “Novosorb” won’t continue to grow alongside Recell, however, Novosorb is also being used in a number of other applications aside from burn treatments.
Having said that, poly will soon need a cash infusion and even if novasorb becomes a standard of care product/process, it is unlikely it will ever be on the level of game changer like Avita is in my humble opinion.
Nonetheless, it should be worth $5 in the near future and who knows beyond that. Im in for 450 shares at 2.10 and will keep following
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
